跳至主要内容
临床试验/NCT00671151
NCT00671151已完成不适用

Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline

Hospital Universitari Son Dureta1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2005年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
1
主要终点
HDAC activity in alveolar macrophages

研究概览

简要总结

Molecular mechanisms of COPD exacerbations and the modulating effect of low dose theophylline on that inflammation are elucidated in this project. NF-kappa B-dependent pathway and acetylation status of nuclear histones are to be studied.Design: controlled, prospective and randomized study with or without theophylline, a potent HDAC activator.Objectives: 1) To determine NF-kB activation, histone deacetylase (HDAC) and histone acetyl-transferase (HAT) activity in sputum macrophages and blood monocytes during an episode of exacerbation and 3 months later, once stability is achieved. To correlate these measurements with inflammatory and oxidative stress markers and with pulmonary function and clinical variables. 2) To assess the effect of theophylline on previous molecular, functional and clinical data. Method: 25 patients with COPD will be recruited during an episode of exacerbation requiring hospitalization. NF-kB activation, HDAC and HAT activity, markers of inflammation and oxidative stress will be determined with specific assays. These determinations will be repeated once the patient is stable and compared with smokers and non smoker controls with normal lung function

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Severe COPD according to GOLD guidelines
  • Age between 40 and 75
  • Admission to hospital due to COPD exacerbation

排除标准

  • History of asthma
  • Pulmonary embolism
  • Pneumonia
  • Other chronic inflammatory disease
  • Patient on theophylline at the time of admission
  • Patient on oral steroids at the time of admission

研究组 & 干预措施

1

Active Comparator

Low-dose theophylline on top of standard therapy for COPD exacerbation

干预措施: Theophylline (Drug)

结局指标

主要结局

HDAC activity in alveolar macrophages

时间窗: 3 months

次要结局

  • Lung function(3 months)
  • Inflammatory cytokine release in sputum and serum(3 months)

研究者

发起方
Hospital Universitari Son Dureta
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Effects of Low-Dose Theophylline During Chronic... | 临床试验